Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential Diagnosis: Retroperitoneal Fibrosis and Oncological Diseases.
Sica A, Casale B, Spada A, Teresa Di Dato M, Sagnelli C, Calogero A, Buonavolontà P, Salzano A, Martinelli E, Saracco E, Troiani T, Anna Dodaro C, Tammaro D, Luisa De Rimini M, Ciardiello F, Papa A. Sica A, et al. Among authors: troiani t. Open Med (Wars). 2019 Dec 26;15:22-26. doi: 10.1515/med-2020-0005. eCollection 2018. Open Med (Wars). 2019. PMID: 31922016 Free PMC article.
Erlotinib in cancer treatment.
Bareschino MA, Schettino C, Troiani T, Martinelli E, Morgillo F, Ciardiello F. Bareschino MA, et al. Among authors: troiani t. Ann Oncol. 2007 Jun;18 Suppl 6:vi35-41. doi: 10.1093/annonc/mdm222. Ann Oncol. 2007. PMID: 17591829 Free article. Review.
Resistance mechanisms of tumour cells to EGFR inhibitors.
Morgillo F, Cantile F, Fasano M, Troiani T, Martinelli E, Ciardiello F. Morgillo F, et al. Among authors: troiani t. Clin Transl Oncol. 2009 May;11(5):270-5. doi: 10.1007/s12094-009-0354-6. Clin Transl Oncol. 2009. PMID: 19451059 Review.
RETRACTED: Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors.
Morgillo F, D'Aiuto E, Troiani T, Martinelli E, Cascone T, De Palma R, Orditura M, De Vita F, Ciardiello F. Morgillo F, et al. Among authors: troiani t. Lung Cancer. 2011 Mar;71(3):283-90. doi: 10.1016/j.lungcan.2010.06.005. Lung Cancer. 2011. Retraction in: Lung Cancer. 2023 Jul;181:107226. doi: 10.1016/j.lungcan.2023.107226 PMID: 20619923 Retracted.
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors.
Morgillo F, Martinelli E, Troiani T, Orditura M, De Vita F, Ciardiello F. Morgillo F, et al. Among authors: troiani t. PLoS One. 2011;6(12):e28841. doi: 10.1371/journal.pone.0028841. Epub 2011 Dec 9. PLoS One. 2011. Retraction in: PLoS One. 2024 Jan 25;19(1):e0298013. doi: 10.1371/journal.pone.0298013 PMID: 22174910 Free PMC article. Retracted.
Targeting EGFR in pancreatic cancer treatment.
Troiani T, Martinelli E, Capasso A, Morgillo F, Orditura M, De Vita F, Ciardiello F. Troiani T, et al. Curr Drug Targets. 2012 Jun;13(6):802-10. doi: 10.2174/138945012800564158. Curr Drug Targets. 2012. PMID: 22458527 Review.
205 results